Successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis and purulent ventriculitis using cefiderocol combination therapy: a case report and literature review.

Eur J Clin Microbiol Infect Dis

Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China.

Published: February 2025

The application of cefiderocol in treating carbapenem-resistant Acinetobacter baumannii (CRAB) central nervous system (CNS) infections is rarely reported. Here we presented the case of a 66-year-old man with CRAB meningitis and purulent ventriculitis successfully treated with a combination antibiotic therapy including cefiderocol. Cerebrospinal fluid (CSF) analysis revealed normalization of glucose, chloride, protein, and lactate levels. CRAB cultures turned negative by Day 7, and metagenomics next generation sequencing (mNGS) results were negative by Day 25. The cefiderocol-contained regimen was continued for 41 days, with no recurrence of CRAB infection and no cefiderocol-associated adverse effects were observed. This case highlighted the potential of cefiderocol as a promising therapeutic option in treating CRAB CNS infections.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10096-025-05077-wDOI Listing

Publication Analysis

Top Keywords

carbapenem-resistant acinetobacter
8
acinetobacter baumannii
8
meningitis purulent
8
purulent ventriculitis
8
cns infections
8
negative day
8
crab
5
successful treatment
4
treatment carbapenem-resistant
4
baumannii meningitis
4

Similar Publications

New antibiotics targeting Gram-negative bacilli.

Infez Med

March 2025

Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.

Antimicrobial resistance (AMR) is an emerging global threat. It increases mortality and morbidity rates and places a heavy burden on healthcare systems. Healthcare professionals can address the increasing issue of AMR by advocating responsible antibiotic use and supporting the development of new medications.

View Article and Find Full Text PDF

Intraventricular injection of eravacycline in the treatment of carbapenem-resistant Acinetobacter baumannii meningitis: a case report.

J Antimicrob Chemother

March 2025

Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, People's Republic of China.

View Article and Find Full Text PDF

Background: Ceftazidime-avibactam and colistin are antibiotics of new and regaining importance used for the treatment of infections caused by multidrug-resistant organisms. The broth microdilution (BMD) test recommended for detecting colistin sensitivity is labor-intensive and difficult to perform under routine conditions. There is a need for alternative methods that produce fast and reliable results in routine laboratory studies.

View Article and Find Full Text PDF

Drinking water plumbing systems are a hot spot for antimicrobial resistant pathogens.

J Hosp Infect

March 2025

Environmental Health, College of Science and Engineering, Flinders University, Bedford Park, 5042, South Australia, Australia; ARC Training Centre for Biofilm Research and Innovation, Flinders University, Australia.

Background: Antimicrobial resistant (AMR) pathogens in drinking water plumbing systems represent a significant yet underestimated public health threat.

Methods: This is the first study to use qPCR and culture-based methods to investigate the prevalence of key AMR threats, methicillin resistant Staphylococcus aureus (MRSA) and carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii, in Australian hospital and residential drinking water and biofilm samples.

Results: Seventy three percent of residential water and biofilm samples were qPCR positive for at least one target pathogen compared with 38% of hospital samples, and 45% of residential plumbing fixtures harboured at least two target pathogens.

View Article and Find Full Text PDF

Dodecapeptides derived from human cathelicidin with potent activity against carbapenem-resistant Acinetobacter baumannii.

Eur J Med Chem

March 2025

State Key Laboratory of Trauma and Chemical Poisoning, Institute of Combined Injury of PLA, College of Preventive Medicine, Army Medical University, Chongqing, 400038, China. Electronic address:

The increasing infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB) poses a serious threat to global public health. Antimicrobial peptides (AMPs) are alternatives to conventional antibiotics in combating superbugs. However, discovering AMPs with low synthesis costs and strong antibacterial effects against CRAB is challenging.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!